Cencora, Inc. Files 8-K Report
Ticker: COR · Form: 8-K · Filed: Aug 5, 2024 · CIK: 1140859
| Field | Detail |
|---|---|
| Company | Cencora, INC. (COR) |
| Form Type | 8-K |
| Filed Date | Aug 5, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01, $250 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, corporate-filing
Related Tickers: ABC
TL;DR
Cencora (ABC) filed an 8-K on Aug 1st - material agreement details to follow.
AI Summary
On August 1, 2024, Cencora, Inc. (formerly AmerisourceBergen Corp) filed an 8-K report detailing a material definitive agreement. The filing also includes other events and financial statements/exhibits. The company is incorporated in Delaware and its principal executive offices are located in Conshohocken, PA.
Why It Matters
This filing indicates a significant contractual event for Cencora, Inc., which could have implications for its business operations and financial standing.
Risk Assessment
Risk Level: low — The filing is a standard 8-K reporting a material definitive agreement, which is routine for public companies and doesn't inherently signal high risk.
Key Numbers
- 1-6671 — Commission File Number (Identifies the specific SEC filing for Cencora, Inc.)
- 23-3079390 — I.R.S. Employer Identification No. (Tax identification number for Cencora, Inc.)
Key Players & Entities
- Cencora, Inc. (company) — Registrant
- AmerisourceBergen Corp (company) — Former company name
- August 1, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Conshohocken, PA (location) — Address of principal executive offices
FAQ
What is the nature of the material definitive agreement filed by Cencora, Inc.?
The filing does not specify the details of the material definitive agreement, only that one was entered into on or before August 1, 2024.
When was Cencora, Inc. formerly known as AmerisourceBergen Corp?
The company's name change from AmerisourceBergen Corp to Cencora, Inc. occurred on May 17, 2001.
What is Cencora, Inc.'s fiscal year end?
Cencora, Inc.'s fiscal year ends on September 30.
Where are Cencora, Inc.'s principal executive offices located?
The principal executive offices of Cencora, Inc. are located at 1 West First Avenue, Conshohocken, PA 19428-1800.
What is the SIC code for Cencora, Inc.?
The Standard Industrial Classification (SIC) code for Cencora, Inc. is 5122, which corresponds to WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES.
Filing Stats: 662 words · 3 min read · ~2 pages · Grade level 10.2 · Accepted 2024-08-05 16:02:04
Key Financial Figures
- $0.01 — f the Company's common stock, par value $0.01 per share (the "Common Stock"), directl
- $250 million — any in the Repurchase was approximately $250 million. The Repurchase was made under the Comp
Filing Documents
- tm2420823d1_8k.htm (8-K) — 29KB
- tm2420823d1_ex10-1.htm (EX-10.1) — 47KB
- 0001104659-24-085811.txt ( ) — 254KB
- cor-20240801.xsd (EX-101.SCH) — 3KB
- cor-20240801_lab.xml (EX-101.LAB) — 33KB
- cor-20240801_pre.xml (EX-101.PRE) — 22KB
- tm2420823d1_8k_htm.xml (XML) — 3KB
01. Entry into a Material Definitive
Item 1.01. Entry into a Material Definitive Agreement. On August 1, 2024, Cencora, Inc. (the "Company") entered into a share repurchase agreement (the "Share Repurchase Agreement") with Walgreens Boots Alliance Holdings LLC (the "Selling Stockholder"), pursuant to which the Company agreed to repurchase 1,039,242 shares of the Company's common stock, par value $0.01 per share (the "Common Stock"), directly from the Selling Stockholder (the "Repurchase"). The price per share paid by the Company is equal to the price per share at which the Selling Stockholder sold shares of Common Stock pursuant to the Rule 144 Sale (as defined below). The Repurchase was consummated on August 5, 2024. The aggregate price paid by the Company in the Repurchase was approximately $250 million. The Repurchase was made under the Company's share repurchase program and the repurchased shares will be held in treasury. The foregoing description of the Share Repurchase Agreement is qualified in its entirety by reference to the full text of the Share Repurchase Agreement filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated by reference herein.
01. Other Events
Item 8.01. Other Events. On August 1, 2024, the Selling Stockholder sold 3,398,929 shares of Common Stock under Rule 144 of the Securities Act of 1933 (the "Rule 144 Sale"). After giving effect to the impact of the Rule 144 Sale and the Repurchase, the Selling Stockholder owns 19,980,000 shares of Common Stock, which represents approximately 10.2% of the 196,007,584 total outstanding shares of Common Stock of the Company (based on 197,046,826 shares of Common Stock outstanding as of July 26, 2024, less the 1,039,242 shares of Common Stock repurchased in the Repurchase).
01. Financial
Item 9.01. Financial (d) Exhibits. Exhibit Number Description 10.1 Share Repurchase Agreement, dated as of August 1, 2024, by and between Cencora, Inc. and Walgreens Boots Alliance Holdings LLC. 104 Cover Page Interactive Data File (formatted as inline XBRL)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Cencora, Inc. August 5, 2024 By: /s/ James F. Cleary Name: James F. Cleary Title: Executive Vice President and Chief Financial Officer